Skip to main content
OpenTrials

Clinical trial condition

Gram-Positive Bacterial Infections

Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.

2,600 public trials 261 recruiting studies
Refine in advanced search Browse all conditions

Gram-Positive Bacterial Infections trial results

Completed

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

NCT01785186

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations
  • TASK Applied Science Bellville, South Africa
  • University of Cape Town, Centre for Tuberculosis Research Innovation Cape Town, South Africa
  • Wits Health Consortium Johannesburg, South Africa
  • The Aurum Institute for Health Research Johannesburg, South Africa
View Trial Details
Completed

Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults

NCT00928785

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +4 more
Locations
  • Hôpital Gabriel Montpied - CHU Clermont-Ferrand Clermont-Ferrand, France
  • Hôpital St Eloi Montpellier, France
  • Groupe Hospitalier Cochin - Saint-Vincent de Paul Paris, France
  • Hôpital Bichat Claude Bernard Paris, France
View Trial Details
Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

NCT01287949

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD investigational site Clermont-Ferrand, France
  • Sanofi Pasteur MSD investigational site Lille, France
  • Sanofi Pasteur MSD investigational site Montpellier, France
  • Sanofi Pasteur MSD investigational site Paris, France
View Trial Details
Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

NCT01546909

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • SPMSD Investigational Site 120 Angers, France
  • SPMSD Investigational Site 103 Arras, France
  • SPMSD Investigational Site 155 Asnières, France
  • SPMSD Investigational Site 125 Bersée, France
View all 45 locations
View Trial Details
Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

NCT01249183

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD Investigational Site Angers, France
  • Sanofi Pasteur MSD Investigational Site Châtellerault, France
  • Sanofi Pasteur MSD Investigational Site Clermont-Ferrand, France
  • Sanofi Pasteur MSD Investigational Site Gières, France
View all 20 locations
View Trial Details

Related conditions